SHAZ is trading 6.6% down at $75.43 following a critical short report from Bleecker Street and mounting dilution concerns.

  • Bleecker Street Research disclosed a short position, questioning SharonAI’s revenue projections and funding structure.
  • The stock is facing additional pressure from share issuance, note conversions, and a prospectus for additional resale shares, reinforcing a significant supply overhang.